Biosenic (FRA:BT1) YoY EPS Growth

: 97.73% (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Biosenic's YoY EPS Growth for the quarter that ended in Jun. 2023 was 97.73%.

Biosenic's Earnings per Share (Diluted) for the six months ended in Jun. 2023 was €-0.17.

Biosenic YoY EPS Growth Historical Data

The historical data trend for Biosenic's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosenic Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

YoY EPS Growth

Get a 7-Day Free Trial

-0.32

42.18

5.56

-1,359.80

99.87

Biosenic Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
YoY EPS Growth	Get a 7-Day Free Trial															40.91	270.71	-1,340.38	-105.02	97.73

Biosenic YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Biosenic's YoY EPS Growth for the fiscal year that ended in Dec. 2022 is calculated as:

	YoY EPS Growth (A: Dec. 2022 )
=	(Earnings per Share (Diluted) (A: Dec. 2022 )	-	Earnings per Share (Diluted) (A: Dec. 2021 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2021 ) \|
=	(-0.02	-	-14.89)	/	\| -14.89 \|
=	99.87 %

Biosenic's YoY EPS Growth for the quarter that ended in Jun. 2023 is calculated as:

	YoY EPS Growth (Q: Jun. 2023 )
=	(Earnings per Share (Diluted) (Q: Jun. 2023 )	-	Earnings per Share (Diluted) (Q: Jun. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Jun. 2022 )) \|
=	(-0.17	-	-7.49)	/	\| -7.49 \|
=	97.73 %

Biosenic YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Biosenic's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosenic (FRA:BT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (FRA:BT1) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

BIOS:Belgium

Address

Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, Gosselies, BEL, 1435

Website

https://www.biosenic.com

Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.

Biosenic (FRA:BT1) Headlines

No Headlines